2015 annual financial data
Avalo Therapeutics 2015 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -11,010,000 USD and net income was -10,490,000 USD.
Operating cash flow was -10,163,380 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -11,010,000 USD
- Net income
- -10,490,000 USD
- Operating cash flow
- -10,163,380 USD